Global provider of therapeutic technologies and services, Cytiva will invest $231 million to expand its facility in Logan, Utah.

The project is expected to create 396 jobs in Cache County over the next 10 years.

“Our work in Logan, Utah enables the development and manufacture of many novel therapeutics,” said Justin Meehan, plant manager at Cytiva. “As global demand for our products and services continues, expanding our operations in Logan will help us deliver for our customers and patients.”

As an incentive the Go Utah Board has approved a post-performance Rural Economic Development Tax Increment Finance (REDTIF) tax credit not to exceed $4,855,064. Each year Cytiva meets the criteria in its contract with the state, it will qualify for a portion of the total tax credit.

“With this expansion, Cytiva continues its multi-year pattern of multi-million dollar investment in Cache County,” said Theresa A. Foxley, president and CEO of EDCUtah. “It’s heartening to see Cytiva’s continued confidence in Hyclone’s legacy, one of Utah’s original BioHive companies, and in Cache County’s future.”

Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies.